Dynavax Technologies reported $221.03M in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Adma Biologics ADMA:US USD 141.37M 1.56M
Agenus AGEN:US USD 13.46M 241K
Amgen AMGN:US USD 38.7B 2.18B
Astrazeneca AZN:US USD 29.3B 229M
AstraZeneca AZN:LN USD 29.3B 229M
Biogen BIIB:US USD 6.28B 998M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Glaxosmithkline GSK:US GBP 22.12B 4M
Neurocrine Biosciences NBIX:US USD 169.2M 200K
Novartis NOVN:VX USD 28.44B 2.59B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Tg Therapeutics TGTX:US USD 70.04M 1.09M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M